-
Journal of Asthma and Allergy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
New therapies and management strategies in the treatment of asthma: patient-focused developments
Review
(3716) Views (1592) Full article downloads
Authors: Joshua Agbetile, Ruth Green
Published Date December 2010
Volume 2011:4 Pages 1 - 12
DOI: http://dx.doi.org/10.2147/JAA.S8671
Joshua Agbetile, Ruth GreenDepartment of Respiratory Medicine and Thoracic Surgery, Institute for Lung Health, Glenfield Hospital, Leicester, UK
Abstract: It is increasingly recognized that large proportions of patients with asthma remain poorly controlled with daily symptoms, limitation in activities, or severe exacerbations despite traditional treatment with inhaled corticosteroids and other agents. This suggests that there is considerable scope for the refinement of traditional guidelines on the use of inhaled therapies in asthma and also a need for the development of novel therapeutic agents, particularly for the treatment of severe asthma. This review aims to discuss a range of emerging treatment approaches in asthma. Firstly, we will set the scene by highlighting the importance of achieving good asthma control in a patient-focused manner and discussing recent work that has furthered our understanding of asthma phenotypes and paved the way for patient-specific treatments. Secondly, we will review new strategies to better use the existing therapies such as inhaled corticosteroids and long-acting β2-agonists that remain the mainstay of treatment for most patients. Finally, we will review the novel therapies that are becoming available, both pharmacological and interventional, and discuss their likely place in the management of this complex disease.
Keywords: asthma, treatments, classification, phenotypes, management
Readers of this article also read:
Immunological and genetic aspects of asthma and allergy
Current recommendations for the treatment of mild asthma
Educational and behavioral interventions for asthma: who achieves which outcomes? A systematic review
Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
Update on optimal use of omalizumab in management of asthma
Clinical update on the use of biomarkers of airway inflammation in the management of asthma
Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D
The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




